Reta GLP-3 (Retatrutide) – 30mg

Description

Retatrutide 30mg is an ultra-high concentration triple-agonist peptide, representing the pinnacle of modern metabolic research. This 30mg lyophilized vial provides an expansive research tool for investigating the simultaneous activation of the GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and GCG (Glucagon) receptors.

Designed for advanced research protocols, Retatrutide is studied for its unprecedented ability to modulate energy expenditure, glucose homeostasis, and systemic metabolic rate through three distinct hormonal pathways.